Objective This study aimed to assess the treatment compliance, patterns, healthcare
resource utilization (HCRU), and costs of anti-epilepsy drugs (AEDs) as the first add-on …

Objective To compare medication adherence and healthcare utilization among patients who
were treated with anti-seizure medications (ASMs) as first add-on to monotherapy for …

Purpose This study aimed to compare health-care utilization and costs in patients treated
with long-acting (LA) vs. short-acting (SA) antiepileptic drug (AED) monotherapy. Methods …

Background Few studies examine predictors of seizures in medically treated patients with
epilepsy receiving antiepileptic monotherapy using a large patient population. Objective Our …

Purpose Treatment for epilepsy primarily involves antiseizure medications (ASMs), which
can be characterized using the clinical data warehouse (CDW) database. In this study, we …

Background This retrospective, observational study used US claims data to assess changes
in antiseizure medication (ASM) drug load for a cohort of patients with epilepsy. Methods …

Background Adherence to antiepileptic drugs (AEDs) remains the primary management tool
to prevent recurrent seizures in patients with epilepsy. Adverse events associated with AEDs …

Abstract Introduction While antiepileptic drugs (AEDs) remain the primary treatment for
epilepsy, many patients continue to have seizures. Uncontrolled seizures may be related to …

Objective This study aimed to examine prescription patterns of antiepileptic drugs (AEDs) for
adult patients with newly diagnosed focal epilepsy in Japan and whether these patterns …

Abstract Purpose How antiepileptic drugs (AEDs) are used in the United States (US) is one
proxy public health indicator for the current state of epilepsy management. The use of …